Morlacco A - Search Results

1

Metabolic syndrome and prostate cancer treatment.

Morlacco A, Zattoni F, Soligo M, Lami V, Iafrate M, Zanovello N, Dal Moro F. Morlacco A, et al. Panminerva Med. 2022 Sep;64(3):359-364. doi: 10.23736/S0031-0808.21.04511-0. Epub 2021 Sep 6. Panminerva Med. 2022. PMID: 34486368 Review.

2

Syphilis or cancer? A urological challenge.

Morlacco A, De Gobbi A, Dal Moro F, Zattoni F. Morlacco A, et al. Urologia. 2015 Oct-Dec;82(4):245-6. doi: 10.5301/uro.5000128. Epub 2015 Aug 4. Urologia. 2015. PMID: 26350045

3

High-risk prostate cancer: the role of surgical management.

Morlacco A, Karnes RJ. Morlacco A, et al. Crit Rev Oncol Hematol. 2016 Jun;102:135-43. doi: 10.1016/j.critrevonc.2016.04.011. Epub 2016 Apr 27. Crit Rev Oncol Hematol. 2016. PMID: 27155934 Review.

4

Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil.

Zattoni F, Kawashima A, Morlacco A, Davis BJ, Nehra AK, Mynderse LA, Froemming AT, Jeffrey Karnes R. Zattoni F, et al. Among authors: morlacco a. Pract Radiat Oncol. 2017 Jan-Feb;7(1):42-49. doi: 10.1016/j.prro.2016.06.003. Epub 2016 Jun 14. Pract Radiat Oncol. 2017. PMID: 27527896

5

Adverse Disease Features in Gleason Score 3 + 4 "Favorable Intermediate-Risk" Prostate Cancer: Implications for Active Surveillance.

Morlacco A, Cheville JC, Rangel LJ, Gearman DJ, Karnes RJ. Morlacco A, et al. Eur Urol. 2017 Sep;72(3):442-447. doi: 10.1016/j.eururo.2016.08.043. Epub 2016 Aug 27. Eur Urol. 2017. PMID: 27574819

6

Treatment of M1a/M1b prostate cancer with or without radical prostatectomy at diagnosis.

Moschini M, Morlacco A, Kwon E, Rangel LJ, Karnes RJ. Moschini M, et al. Among authors: morlacco a. Prostate Cancer Prostatic Dis. 2017 Mar;20(1):117-121. doi: 10.1038/pcan.2016.63. Epub 2017 Jan 3. Prostate Cancer Prostatic Dis. 2017. PMID: 28045114

7

Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: a multi-institutional study of 62 patients.

Spahn M, Morlacco A, Boxler S, Joniau S, Briganti A, Montorsi F, Gontero P, Bader P, Frohneberg D, van Poppel H, Karnes RJ; European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPAcT). Spahn M, et al. Among authors: morlacco a. BJU Int. 2017 Nov;120(5B):E52-E58. doi: 10.1111/bju.13818. Epub 2017 Mar 26. BJU Int. 2017. PMID: 28220605

8

Genomic tests to guide prostate cancer management following diagnosis.

Colicchia M, Morlacco A, Cheville JC, Karnes RJ. Colicchia M, et al. Among authors: morlacco a. Expert Rev Mol Diagn. 2017 Apr;17(4):367-377. doi: 10.1080/14737159.2017.1302332. Epub 2017 Mar 13. Expert Rev Mol Diagn. 2017. PMID: 28277880 Review.

9

Development of a Surgical Safety Training Program and Checklist for Conversion during Robotic Partial Nephrectomies.

Zattoni F, Morlacco A, Cattaneo F, Soligo M, Meggiato L, Modonutti D, Valotto C, Dal Moro F, Zattoni F. Zattoni F, et al. Among authors: morlacco a. Urology. 2017 Nov;109:38-43. doi: 10.1016/j.urology.2017.06.057. Epub 2017 Aug 18. Urology. 2017. PMID: 28827196 Clinical Trial.

10

Comparison of Pathological and Oncologic Outcomes of Favorable Risk Gleason Score 3 + 4 and Low Risk Gleason Score 6 Prostate Cancer: Considerations for Active Surveillance.

Gearman DJ, Morlacco A, Cheville JC, Rangel LJ, Karnes RJ. Gearman DJ, et al. Among authors: morlacco a. J Urol. 2018 May;199(5):1188-1195. doi: 10.1016/j.juro.2017.11.116. Epub 2017 Dec 7. J Urol. 2018. PMID: 29225057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page